Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Impact of immunotherapy on lymphoma

Caron Jacobson • 2 Jun 2020
EHA 2020
Lymphoma BiTEs CAR-T

Caron Jacobson, MD, MMSc, Dana-Farber Cancer Institute, Boston, MA, explores the revolutionary impact of immunotherapy on lymphoma and highlights burgeoning areas in this field. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Caron Jacobson

Rapid CAR manufacture
Caron Jacobson et al. • 14 Apr 2023
10:21
Advances in CAR-T therapy for lymphoma
Caron Jacobson et al. • 1 May 2022
2:13
Expanding the reach of CAR-T
Caron Jacobson • 2 Jun 2020
4:51
ZUMA-5: Axi-cel for R/R non-Hodgkin lymphoma
Caron Jacobson • 28 May 2020

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals